Chronic GVHD after mismatch unrelated donor stem cell transplantation (9/10) may be associated with PIRCHE (predicted indirectly recognizable HLA epitopes) calculated from six loci HLA

被引：0

作者：

Grabowska, M. ^{[1
]}

Moskalik-Kierat, D. ^{[1
]}

Brzoza, M. ^{[1
]}

Wasilewska, A. ^{[1
]}

Rusicka-Krzewska, P. ^{[1
]}

Machowicz, R. ^{[1
]}

Kacprzyk, P. ^{[1
]}

Chmielewska, L. ^{[1
]}

Bilinski, J. ^{[1
]}

Boguradzki, P. ^{[1
]}

Karakulska-Prystupiuk, E. ^{[1
]}

Jedrzejczak, W. W. ^{[1
]}

Tomaszewska, A. ^{[1
]}

Basak, G. W. ^{[1
]}

机构：

[1] Med Univ Warsaw, Univ Clin Ctr, Warsaw, Poland

来源：

BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P535

引用

页码：389 / 390

页数：2

共 50 条

[41] Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings
Michallet, Mauricette
Sobh, Mohamad
Morisset, Stephane
Detrait, Marie Y.
Labussiere, Helene
Ducastelle, Sophie
Barraco, Fiorenza
Fattoum, Jihane
Chelghoum, Youcef
Thomas, Xavier
Nicolini, Franck E.
BLOOD, 2011, 118 (21) : 1333 - 1334
[42] Cyclophosphamide-Based GVHD Prophylaxis After 9/10 and 10/10 HLA Tissue-Matched Unrelated Allogeneic Stem Cell Transplantation: A Multi-Center Experience
Yildirim, Murat
Sayin, Selim
Comert, Melda
Yilmaz, Esra Safak
Avcu, Ferit
Ural, Ali Ugur
Ayli, Meltem
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S288 - S288
[43] IS THE USE OF 9/10 HLA UNRELATED DONORS STILL ACCEPTABLE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES? COMPARISON WITH TRANSPLANTS FROM 10/10 HLA UNRELATED DONORS AND SIBLINGS
Michallet, M.
Sobh, M.
Morisset, S.
Detrait, M.
Labussiere, H.
Tedone, N.
Ducastelle, S.
Barraco, F.
Chelghoum, Y.
Thomas, X.
Nicolini, F. E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S327 - S328
[44] HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
Nowak, Jacek
Nestorowicz, Klaudia
Graczyk-Pol, Elzbieta
Mika-Witkowska, Renata
Rogatko-Koros, Marta
Jaskula, Emilia
Koscinska, Katarzyna
Madej, Sylwia
Tomaszewska, Agnieszka
Nasilowska-Adamska, Barbara
Szczepinski, Andrzej
Halaburda, Kazimierz
Dybko, Jaroslaw
Kuliczkowski, Kazimierz
Czerw, Tomasz
Giebel, Sebastian
Holowiecki, Jerzy
Baranska, Malgorzata
Pieczonka, Anna
Wachowiak, Jacek
Czyz, Anna
Gil, Lidia
Lojko-Dankowska, Anna
Komarnicki, Mieczyslaw
Bieniaszewska, Maria
Kucharska, Agnieszka
Hellmann, Andrzej
Gronkowska, Anna
Jedrzejczak, Wieslaw W.
Markiewicz, Miroslaw
Koclega, Anna
Kyrcz-Krzemien, Slawomira
Mielcarek, Monika
Kalwak, Krzysztof
Styczynski, Jan
Wysocki, Mariusz
Drabko, Katarzyna
Wojcik, Beata
Kowalczyk, Jerzy
Gozdzik, Jolanta
Pawliczak, Daria
Gwozdowicz, Slawomir
Dziopa, Joanna
Szlendak, Urszula
Witkowska, Agnieszka
Zubala, Marta
Gawron, Agnieszka
Warzocha, Krzysztof
Lange, Andrzej
HUMAN IMMUNOLOGY, 2018, 79 (06) : 403 - 412
[45] Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch
Al Malki, Monzr M.
Gendzekhadze, Ketevan
Yang Dongyun
Mokhtari, Sally
Parker, Pablo
Karanes, Chatchada
Palmer, Joycelynne
Snyder, David
Forman, Stephen J.
Nademanee, Auayporn
Nakamura, Ryotaro
TRANSPLANTATION, 2020, 104 (05) : 1070 - 1080
[46] HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation
Ducreux, Stephanie
Dubois, Valerie
Amokrane, Kahina
Yakoub-Agha, Ibrahim
Labalette, Myriam
Michallet, Mauricette
Rubio, Marie-Therese
Kennel, Anne
Forcade, Edouard
Lafarge, Xavier
Bulabois, Claude-Eric
Masson, Dominique
Daguindau, Etienne
Devys, Anne
Moalic, Virginie
Quelvennec, Erwann
Boudifa, Abdelali
Picard, Christophe
Van Endert, Peter
de Matteis, Muriel
Delbos, Florent
Filloux, Matthieu
Pedron, Beatrice
Renac, Virginie
Hau, Francoise
Bonneau, Julie
Parissiadis, Anne
Fort, Marylise
Dormoy, Anne
Maillard, Natacha
Jollet, Isabelle
Chevallier, Patrice
Cesbron, Anne
Bay, Jacques-Olivier
Quainon, Fabienne
Garnier, Federico
Socie, Gerard
Loiseau, Pascale
Porcher, Raphael
Peffault de Latour, Regis
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (08) : 994 - 1001
[47] Comparable outcome after 10/10 and 9/10 HLA-matched unrelated donor stem cell transplantation (HSCT) using post-transplant cyclophosphamide (PTCY) for GVHD prophylaxis, on behalf of the ALWP-EBMT
Lorentino, Francesca
Labopin, Myriam
Ciceri, Fabio
Vago, Luca
Fleischhauer, Katharina
Afanasyev, Boris
Kroeger, Nicolaus
Cornelissen, Jan J.
Lovira, Montserrat
Meijer, Ellen
Vitek, Antonin
Elmaagacli, Ahmet
Blaise, Didier
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2019, 54 : 136 - 137
[48] Predicted Indirectly Recognizable HLA Epitopes Are Associated with T-cell Mediated Rejection among Kidney Transplant Recipients with Preformed and De Novo Donor-Reactive T-cells.
Schachtner, T.
Stein, M.
Otto, N. M.
Reinke, P. M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 502 - 502
[49] Immunopeptidome divergence of HLA class I mismatches predicts survival after 9/10 matched unrelated stem cell transplantation
Crivello, Pietro
Arrieta-Bolanos, Esteban
He, Meilun
Wang, Tao
Gadalla, Shahinaz M.
Paczesny, Sophie
Marsh, Steven G. E.
Lee, Stephanie J.
Spellman, Stephen R.
Bolon, Yung-Tsi
Fleischhauer, Katharina
HLA, 2022, 99 (05) : 418 - 419
[50] PROFOUND T-CELL RESPONSE AGAINST HLA-DRB3 ASSOCIATED WITH SEVERE GVHD AFTER PURIFIED CD4+T-CELL INFUSION FROM AN HLA 10/10 MATCHED UNRELATED DONOR
van Balen, P.
van Luxemburg-Heijs, S. A.
van Bergen, C. A.
Halkes, C. J.
Jedema, I.
Falkenburg, J.
BONE MARROW TRANSPLANTATION, 2014, 49 : S28 - S28

← 1 2 3 4 5 →